205 related articles for article (PubMed ID: 20077431)
1. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG
J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
[TBL] [Abstract][Full Text] [Related]
3. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.
Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG
Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338
[TBL] [Abstract][Full Text] [Related]
4. Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Guo SD; Liu CY; Yu JW; Chai Z; Wang Q; Mi XT; Song GB; Li YH; Yang PW; Feng L; Xiao BG; Ma CG
CNS Neurosci Ther; 2019 Jun; 25(6):783-795. PubMed ID: 30779332
[TBL] [Abstract][Full Text] [Related]
5. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Liu C; Li Y; Yu J; Feng L; Hou S; Liu Y; Guo M; Xie Y; Meng J; Zhang H; Xiao B; Ma C
PLoS One; 2013; 8(2):e54841. PubMed ID: 23418431
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis.
Zhao YF; Zhang X; Ding ZB; Yang XW; Zhang H; Yu JZ; Li YH; Liu CY; Zhang Q; Zhang HZ; Ma CG; Xiao BG
J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG
Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093
[TBL] [Abstract][Full Text] [Related]
8. Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages.
Liu CY; Guo SD; Yu JZ; Li YH; Zhang H; Feng L; Chai Z; Yuan HJ; Yang WF; Feng QJ; Xiao BG; Ma CG
Eur J Immunol; 2015 Jan; 45(1):142-52. PubMed ID: 25287052
[TBL] [Abstract][Full Text] [Related]
9. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J
J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142
[TBL] [Abstract][Full Text] [Related]
10. [Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice].
Liu C; Guo S; Zhang N; Yu J; Xiao B; Ma C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 41(3):225-32. PubMed ID: 27033784
[TBL] [Abstract][Full Text] [Related]
11. Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Chen C; Yu JZ; Zhang Q; Zhao YF; Liu CY; Li YH; Yang WF; Ma CG; Xiao BG
Neuromolecular Med; 2015 Dec; 17(4):454-65. PubMed ID: 26481340
[TBL] [Abstract][Full Text] [Related]
12. Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Yu JZ; Chen C; Zhang Q; Zhao YF; Feng L; Zhang HF; Meng J; Ma CG; Xiao BG
Wound Repair Regen; 2016 Mar; 24(2):317-27. PubMed ID: 26789651
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
[TBL] [Abstract][Full Text] [Related]
14. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Li M; Li Y; Liu X; Gao X; Wang Y
J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
[TBL] [Abstract][Full Text] [Related]
15. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist.
Lou ZY; Zhao CB; Xiao BG
J Neurosci Res; 2012 Jan; 90(1):84-95. PubMed ID: 21922514
[TBL] [Abstract][Full Text] [Related]
17. Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis.
Pineda AA; Minohara M; Kawamura N; Matsushita T; Yamasaki R; Sun X; Piao H; Shimokawa H; Kira J
J Neurol Sci; 2011 Jul; 306(1-2):115-20. PubMed ID: 21501850
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG
Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
20. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
